A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 480 participants.
Also called NCT01923740
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose other
- Phase
- Not applicable
- Enrolled
- 480 participants
- Sponsor
- Registry
-
NCT01923740
-
- Other papers using this trial's data
- Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01923740. Randomized; no masking; primary purpose other. Start 2013-07 (registry gives no type); primary completion 2015-05 (actual). Results posted on 2018-02-14.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT)
- Acronym
- ABSORB CHINA
- Condition
- Coronary Artery Disease
- Condition
- Coronary Artery Stenosis
- Condition
- Coronary Disease
- Condition
- Coronary Stenosis
- Intervention (Device)
- XIENCE V EECSS
- Intervention (Device)
- Absorb BVS System
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct01923740- Content hash
e18da3531c225214c84adde1bff53581fb04914cdda541c6b51c5bc9d04b0c52